MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jtha.2025.09.027

Медицинская библиотека · Journal of thrombosis and haemostasis : JTH · 2025

Microthrombi growth in ADAMTS13 deficiency exacerbates inflammatory bowel disease via mucosal and endothelial dysfunction.

Tatsuta Kyota, Honkura Naoki, Morooka Nanami, Sakata Mayu, Kurachi Kiyotaka, Sugimoto Ken, Kokame Koichi, Takeuchi Hiroya, Urano Tetsumei, Suzuki Yuko

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by mucosal inflammation and ulceration. While von Willebrand factor, typically cleaved by ADAMTS13 from ultralarge multimers into smaller fragments, has been found to accumulate in the inflamed lesions of the ADAMTS13-deficient colitis model, the association between aberrant thrombus formation in lesional microvessels and colitis exacerbation remains unclear.

OBJECTIVES

We investigated potential linkages between microthrombus formation and colitis progression.

METHODS

Plasma and inflamed colonic tissues from patients with UC were analyzed. We employed intravital multiphoton microscopy to reveal the real-time structural dynamics of the mucus layer and mucosal vasculature at single-cell spatial resolution in a dextran sulfate sodium-induced colitis model of wild-type and ADAMTS13-deficient green fluorescent protein-expressing mice.

RESULTS

Patients with UC exhibited significantly reduced plasma ADAMTS13 activity and excessive von Willebrand factor deposition in inflamed colonic tissues. In dextran sulfate sodium-induced colitis mice, ADAMTS13 deficiency showed heightened disease activity and increased mucosal erosion in histochemical analysis compared with wild-type mice. A novel methodology appraised colonic mucus barrier integrity by visualizing fluorescent dextran penetration from the colonic lumen to crypts. ADAMTS13 deficiency accelerated mucus layer disruption, leukocyte recruitment, and microthrombus formation, particularly in periepithelium regions. Vessel-specific analyses demonstrated that obstructive microthrombi were most prominent in the mucosal layer, contributing to local ischemia and mucosal erosion. Recombinant human ADAMTS13 alleviated microthrombus formation, improved mucosal integrity, and mitigated colitis severity in both wild-type and ADAMTS13-deficient mice.

CONCLUSION

Advanced intravital imaging analysis revealed that obstructive thrombi formed in mucosal vessels due to impaired ADAMTS13 activity were essential for colitis severity.

Для цитирования: Tatsuta Kyota, Honkura Naoki, Morooka Nanami, Sakata Mayu, Kurachi Kiyotaka, Sugimoto Ken, Kokame Koichi, Takeuchi Hiroya, Urano Tetsumei, Suzuki Yuko. Microthrombi growth in ADAMTS13 deficiency exacerbates inflammatory bowel disease via mucosal and endothelial dysfunction.. Journal of thrombosis and haemostasis : JTH. 2025. DOI: 10.1016/j.jtha.2025.09.027.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.